Jayant Manglik, President, Religare Broking, advises investors to following a buy on dips approach
"Nifty has to cross 10,555 levels decisively for further upmove. Sustenance trade above 10,555 marks may add momentum on upside till 10,650-10,670 levels," says RajeshAgarwal of AUM Capital.
Prakash Gaba of prakashgaba.com recommends buying CG Power with target at Rs 84 and stop loss at Rs 81.50, a buy on ITC with target at Rs 275 and stop loss at Rs 265 and a buy also on Jet Airways with target at Rs 680 and stop loss at Rs 630.
"Nifty has crossed last week high and heading towards 10250-10270 levels i.e. Upper Band of Falling Channel which might work as immediate resistance. Sustenance trade above these levels may add further momentum on upside," says Rajesh Agarwal of AUM Capital.
The company has received final approval from the US drug regulator to market oseltamivir phosphate capsules, a generic version of Hoffman-La Roche Inc's Tamiflu capsules.
Lupin Limited announced that it has entered into a research and development agreement with Medicis Pharmaceutical Corporation (“Medicis”) to apply proprietary Lupin formulation technologies to multiple therapeutic compounds.
Pharma Major, Lupin Limited, announced today that its Australian subsidiary, Generic Health Pty Ltd. has acquired the worldwide rights to the GOANNA® brand and the complete range of premium therapeutic oils, rubs and ointments marketed under the brand.